CO5680415A2 - Procedimiento para preparar un compuesto de azabiciclo [3,1,0]hexano - Google Patents

Procedimiento para preparar un compuesto de azabiciclo [3,1,0]hexano

Info

Publication number
CO5680415A2
CO5680415A2 CO06033239A CO06033239A CO5680415A2 CO 5680415 A2 CO5680415 A2 CO 5680415A2 CO 06033239 A CO06033239 A CO 06033239A CO 06033239 A CO06033239 A CO 06033239A CO 5680415 A2 CO5680415 A2 CO 5680415A2
Authority
CO
Colombia
Prior art keywords
hexane
azabicyclo
azabiciclo
hexano
prepare
Prior art date
Application number
CO06033239A
Other languages
English (en)
Inventor
John J Teixeira
L Derek Tickner
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CO5680415A2 publication Critical patent/CO5680415A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)

Abstract

1.- Un procedimiento para preparar un compuesto de azabiciclo[3.1.0]hexano que tiene menos impurezas que comprende poner en contacto una mezcla que contiene un compuesto de azabiciclo[3.1.0]hexano y al menos una impureza relacionada con el procedimiento en una primera concentración con un alcohol; y recuperar de dicha mezcla dicho compuesto de azabiciclo[3.1.0]hexano, teniendo dicha al menos una impureza relacionada con el procedimiento a una segunda concentración, siendo menor dicha segunda concentración que dicha primera concentración.2.- El procedimiento de la reivindicación 1, en el que dicho compuesto de azabiciclo[3.1.0]hexano es un compuesto de 3-azabiciclo[3.1.0]hexano.
CO06033239A 2003-10-06 2006-04-05 Procedimiento para preparar un compuesto de azabiciclo [3,1,0]hexano CO5680415A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50908803P 2003-10-06 2003-10-06

Publications (1)

Publication Number Publication Date
CO5680415A2 true CO5680415A2 (es) 2006-09-29

Family

ID=34421799

Family Applications (1)

Application Number Title Priority Date Filing Date
CO06033239A CO5680415A2 (es) 2003-10-06 2006-04-05 Procedimiento para preparar un compuesto de azabiciclo [3,1,0]hexano

Country Status (16)

Country Link
US (1) US7153976B2 (es)
EP (1) EP1678136A1 (es)
JP (1) JP2007507484A (es)
KR (1) KR100767895B1 (es)
CN (1) CN1863772A (es)
AR (1) AR046093A1 (es)
AU (1) AU2004278159A1 (es)
BR (1) BRPI0415062A (es)
CA (1) CA2540637A1 (es)
CO (1) CO5680415A2 (es)
IL (1) IL174415A0 (es)
MX (1) MXPA06003811A (es)
NO (1) NO20061283L (es)
RU (1) RU2006111094A (es)
TW (1) TW200526578A (es)
WO (1) WO2005033080A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1440059B1 (en) * 2001-10-22 2008-04-16 Pfizer Products Inc. 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists
SI1725234T1 (sl) 2004-03-05 2013-04-30 The Trustees Of The University Of Pennsylvania Postopki zdravljenja nepravilnosti ali bolezni povezanih s hiperlipidemijo in hiperholesterolemijo z minimiziranjem stranskih uäśinkov
JP2013542929A (ja) 2010-09-28 2013-11-28 パナセア バイオテック リミテッド 新規ビシクロ環化合物
EP3072884B1 (en) 2013-11-20 2020-01-01 Sanwa Kagaku Kenkyusho Co., Ltd. 3-azabicyclo[3.1.0]hexane derivative and use thereof for medical purposes
EP3299357A4 (en) 2015-05-20 2018-11-14 Sanwa Kagaku Kenkyusho Co., Ltd. Crystal of salt of novel 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof
CN114057627B (zh) * 2022-01-18 2022-04-01 南京桦冠生物技术有限公司 一种丙型肝炎及新冠药物中间体及其盐的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB948730A (en) 1959-04-08 1964-02-05 Wellcome Found Substituted cyclopropanes and related compounds
US4231935A (en) 1975-07-31 1980-11-04 American Cyanamid Company 1-Phenyl-3-azabicyclo[3.1.0]hexanes
JPH08325228A (ja) * 1995-05-29 1996-12-10 Sumitomo Chem Co Ltd ビシクロヘキサンアミン誘導体の製造法
EP1440059B1 (en) * 2001-10-22 2008-04-16 Pfizer Products Inc. 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists

Also Published As

Publication number Publication date
NO20061283L (no) 2006-06-29
JP2007507484A (ja) 2007-03-29
MXPA06003811A (es) 2006-06-14
IL174415A0 (en) 2006-08-01
BRPI0415062A (pt) 2006-11-28
TW200526578A (en) 2005-08-16
US7153976B2 (en) 2006-12-26
KR20060085631A (ko) 2006-07-27
CA2540637A1 (en) 2005-04-14
AR046093A1 (es) 2005-11-23
EP1678136A1 (en) 2006-07-12
KR100767895B1 (ko) 2007-10-17
CN1863772A (zh) 2006-11-15
WO2005033080A1 (en) 2005-04-14
US20050075387A1 (en) 2005-04-07
AU2004278159A1 (en) 2005-04-14
RU2006111094A (ru) 2006-08-27

Similar Documents

Publication Publication Date Title
CO5680415A2 (es) Procedimiento para preparar un compuesto de azabiciclo [3,1,0]hexano
CU22939A3 (es) Proceso para la síntesis de 1,3 dioles
PT1789160E (pt) Método para a separação de cloreto de hidrogénio e fosgénio
DE60111247D1 (de) Verfahren für die produktion von peptiden unter verwendung eines in vitro transkription/translation system
TW200501462A (en) Method to produce semiconductor-chips
AR055649A1 (es) Metodo de mejora de la funcion cognitiva
CY1106780T1 (el) Διαδικασια και εγκατασταση ταυτοχρονης παραγωγης υγροποιησιμου φυσικου αεριου και τμηματος υγρων φυσικου αεριου
BRPI0513237A (pt) hidrolisados de proteìna para diminuição de pressão sanguìnea
NO20015400L (no) Clostridiumstammer som produserer etanol fra substratinneholdende gasser
GB0107636D0 (en) Method
BRPI0507886A (pt) método de purificação de albumina compreendendo uma etapa de nanofiltração, solução e composição para uso terapêutico contendo-o
RU2004118503A (ru) Способ получения инсулиновых соединений
UY28558A1 (es) Proteína
UA89061C2 (ru) Способ получения циклопентанона и применение углеводородной смеси, которая содержит циклопентен
AU2003258591A1 (en) Method for producing ipda with a high cis/trans isomer ratio by distillation
AU2003291987A1 (en) Method for regenerating a hydrogenation catalyst
ATE452180T1 (de) Blakeslea trispora zur herstellung von lycopin in hoher ausbeute, in einem geeigneten medium in abwesenheit eines exogenen corotenogenese- hemmstoffes
ES2156735B1 (es) Procedimiento de produccion de licopeno.
BR0306974A (pt) Métodos para produzir e conformar um recipiente de bateria, e, recipiente de bateria
ATE291006T1 (de) Verfahren zur herstellung von salbutamolisomeren
DE60223202D1 (de) Verfahren zur niederdruck-aufkohlung
AU2003263200A1 (en) Method for the production of isophorondiamine (ipda, 3-aminomethyl-3,5,5-trimethylcyclohexylamine) having a high cis/trans-isomer ratio
BRPI0416274A (pt) método para produzir solução de amÈnio de ácido orgánico
BR0318317A (pt) composição de matéria que é hidróxido de alumìnio, e, método para a produção de hidróxido de alumìnio no processo bayer
ES2530760T3 (es) Peptidasas de basidiomicetos

Legal Events

Date Code Title Description
FC Application refused